Texas Instruments Incorporated
TXNLast close · Oct 16, 2026276.48−2.64 (−0.95%)
Market cap$252.5B
12 firms' latest targets, last 90 days: median $320.00 ($225.00–$405.00), 16% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-07-29 | Arete Research | $405.00 | — | +46% |
| 2026-07-23 | UBS | $380.00 | ▲ 9% | +37% |
| 2026-07-23 | Mizuho Securities | $305.00 | ▲ 2% | +10% |
| 2026-07-23 | Baird | $385.00 | ▲ 28% | +39% |
| 2026-07-23 | Evercore ISI | $330.00 | — | +19% |
| 2026-07-23 | Truist | $300.00 | ▲ 8% | +9% |
| 2026-07-23 | KeyBanc | $400.00 | ▲ 3% | +45% |
| 2026-07-23 | Bernstein | $290.00 | ▲ 41% | +5% |
| 2026-07-23 | Morgan Stanley | $255.00 | ▲ 11% | -8% |
| 2026-07-23 | Wells Fargo | $310.00 | ▲ 3% | +12% |
| 2026-07-23 | Goldman Sachs | $225.00 | ▲ 29% | -19% |
| 2026-07-21 | Susquehanna | $340.00 | ▲ 13% | +23% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $17.5B | -13% | $7.07 | -25% | est. $17.6B+0% | est. $7.06 | 20 |
| 2024reported | $15.6B | -11% | $5.20 | -26% | est. $15.5B+1% | est. $5.10 | 20 |
| 2025reported | $17.7B | +13% | $5.45 | +5% | est. $17.7B+0% | est. $5.47 | 23 |
| 2026 | $22.0B | +24% | $8.52 | +56% | $21.5B–$22.4B | $7.94–$9.08 | 24 |
| 2027 | $25.0B | +14% | $10.33 | +21% | $23.3B–$26.4B | $9.60–$11.57 | 25 |
| 2028 | $27.7B | +11% | $12.05 | +17% | $24.4B–$35.3B | $10.11–$17.98 | 25 |
| 2029 | $29.7B | +7% | $11.32 | -6% | $27.8B–$33.1B | $10.38–$13.00 | 12 |
| 2030 | $33.6B | +13% | $12.16 | +7% | $31.4B–$37.4B | $11.15–$13.97 | 12 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.